HDAC9 and neoplasm: In conclusion, resveratrol can enhance the antitumour effect of cisplatin by modulating HDAC activity and HSP70 and HSP90 levels, thus contributing to direct toxicity on tumour cells and tumour growth, and consequently prolonging mice life.